Scarica l'app Stockscreener
23.63
0.38%
-0.09
Dopo l'orario di chiusura:
24.00
0.37
+1.57%
Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie
Mineralys Therapeutics Announces Presentation of - GlobeNewswire
Mineralys Therapeutics, Inc. (MLYS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 144 Mineralys Therapeutics For: 1 October By Investing.com - Investing.com Canada
A 75,000-share sale is proposed by a Mineralys (MLYS) officer and director. - Stock Titan
Two new hires at Mineralys receive options on 46,430 shares and stock awards tied to 34,823 shares. - Stock Titan
Mineralys Therapeutics (MLYS) Faces A Fresh Valuation Test On New Lorundrostat Data - Yahoo Finance
Mineralys to Present Long-Term Lorundrostat Data in November - MyChesCo
Form 144 MINERALYS THERAPEUTICS For: 27 September By Investing.com - Investing.com India
Mineralys Sets Investor Forum Appearance as Lorundrostat Advances - MyChesCo
Form 4 Mineralys Therapeutics Inc For: 24 September By Investing.com - Investing.com Canada
Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com Nigeria
Mineralys Therapeutics director sells $3 million in shares - Investing.com
A fund sold Mineralys (MLYS) shares and still holds more than 7.8 million. - Stock Titan
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - GlobeNewswire
Mineralys to present lorundrostat trial data at AHA meeting By Investing.com - Investing.com Canada
Mineralys to present lorundrostat trial data at AHA meeting - Investing.com India
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026 - The Manila Times
Mineralys Therapeutics’ Transform-HTN Open-Label Extension - GlobeNewswire
Form 144 Mineralys Therapeutics For: 23 September By Investing.com - Investing.com Nigeria
Form 4 Mineralys Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada
Mineralys Therapeutics CCO Eric Warren sells $209k in stock - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $209k in stock By Investing.com - Investing.com Nigeria
Mineralys Therapeutics (MLYS) CCO sells 7,438 shares in pre-set plan - Stock Titan
Fund may sell Mineralys (NASDAQ: MLYS) shares; filing shows the size - Stock Titan
(MLYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Promising 71% Upside Potential In Biotech - DirectorsTalk Interviews
Mineralys Therapeutics (MLYS) officer lines up new stock option sale - Stock Titan
A new employee gets Mineralys stock awards covering 14,880 and 11,160 shares - Stock Titan
Mineralys Therapeutics director Karydas sells $85,740 in stock By Investing.com - Investing.com Canada
Mineralys Therapeutics director Karydas sells $85,740 in stock - Investing.com
Mineralys Therapeutics (MLYS) director sells shares under preset plan - Stock Titan
Mineralys Therapeutics (NASDAQ: MLYS) executive plans new stock option sale after recent $388K trade - Stock Titan
Mineralys (NASDAQ: MLYS) officer to sell 3,000 shares via options - Stock Titan
Mineralys Grants Equity Awards to Two New Employees - mychesco.com
Mineralys (MLYS) officer to sell 7,709 shares - Stock Titan
Understanding the Setup: (MLYS) and Scalable Risk - Stock Traders Daily
Mineralys Therapeutics grants inducement equity awards covering 52,080 shares to new hires - Bitget
Mineralys at Wells Fargo conference: lorundrostat launch takes shape By Investing.com - Investing.com Canada
MLYS: Lorundrostat nears approval with strong data, broad market prep, and a focus on parity access - TradingView
Mineralys Therapeutics (NASDAQ: MLYS) insider to sell 2,171 shares via cashless option exercise - Stock Titan
Two new hires get four-year stock awards from Mineralys - Stock Titan
Mineralys Therapeutics Market Sentiment - Benzinga España
BEAM Stock Price and Chart — NASDAQ:BEAM - TradingView
Mineralys Therapeutics upgraded to Buy ahead of lorundrostat FDA approval and strong market launch. - Pluang
Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision (MLYS) - Seeking Alpha
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares By Investing.com - Investing.com Nigeria
Mineralys (NASDAQ: MLYS) CCO sells 7,437 shares under 10b5-1 plan - Stock Titan
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):